Now accepting site applications for Q3 2026Apply Now →
Press & media.

Media Inquiries

Contact our communications team for press inquiries, interview requests, company information, and access to media resources.

Get in Touch

Our communications team is available to assist journalists, analysts, and media professionals with press inquiries, interview coordination, fact-checking requests, and access to company information and data.

For time-sensitive media requests, please indicate your deadline in your initial outreach. We make every effort to respond to press inquiries within one business day.

Media Relations Email

media@clinitiative.com

General Inquiries

info@clinitiative.com

Phone

(713) 555-0140

Coverage Areas

Clinitiative leadership and subject matter experts are available to comment on topics across clinical trial operations, including:

Clinical trial site selection and enrollment optimization
Governance frameworks for multi-site clinical trials
Site network operations and performance benchmarking
Investigator training and workforce development
Regulatory trends affecting clinical research sites
Diversity and inclusion in clinical trial enrollment
Decentralized and hybrid trial implementation
Technology adoption at clinical research sites

Recent Press Releases

The latest announcements from Clinitiative Health Research. For full press release text or additional context, contact our media relations team.

February 2026

Clinitiative Launches Principal Investigator Training Program

New four-week certification course prepares physicians for PI responsibilities across all therapeutic areas.

January 2026

Clinitiative Network Surpasses 200 Active Clinical Trial Sites

Milestone expansion brings governance-first clinical trial infrastructure to 38 states and 14 therapeutic areas.

November 2025

SiteScore™ Methodology Published in Peer-Reviewed Journal

Independent validation confirms SiteScore™ predictive accuracy for site enrollment performance across Phase II and III trials.

September 2025

Annual Network Report Reveals 52% Reduction in Under-Enrolling Sites

ClinFirst™ governance framework demonstrates measurable impact on enrollment performance and trial timeline adherence.

Media Resources

The following resources are available to credentialed media professionals upon request. Please contact our communications team to obtain access.

Company Overview

Clinitiative Health Research is a governance-first clinical trial site network providing site selection, enrollment optimization, and operational infrastructure to sponsors and CROs conducting multi-site clinical trials across the United States.

Leadership Bios

Executive biographies and professional headshots are available upon request for publication in trade media, conference programs, and industry directories.

Brand Assets

Approved logos, wordmarks, and brand guidelines are available for authorized media use. All assets must be used in accordance with Clinitiative brand standards.

Data & Research Citations

Journalists and analysts may request permission to cite data from Clinitiative white papers, research briefs, and the Annual Network Report for editorial and research purposes.

Editorial Guidelines

When referencing Clinitiative Health Research in publications, please observe the following guidelines.

Company Name

The full company name is “Clinitiative Health Research.” On second reference, “Clinitiative” is acceptable. Please do not abbreviate to “CHR” or use other shortened forms without prior approval.

Product Trademarks

ClinFirst™, SiteScore™, and KOLScore™ are trademarks of Clinitiative Health Research. Please include the trademark symbol on first reference in any publication.

Data Attribution

All data, statistics, and research findings sourced from Clinitiative publications should be attributed to “Clinitiative Health Research” with the specific publication title and date referenced.

Have a Media Request?

Reach out to our communications team for interviews, press materials, or company information.